Ann: Approval received to continue with Human Cancer Trial, page-6

Homer, Where did you get this information from, announcement put out by PAA on 21/10/14 states:

PharmAust Limited (“PharmAust”) (ASX: PAA & PAAO) is pleased to report that it is now advancing to the treatment of the second patient in its “First in Man” trial with PPL-1. Following the approval of the study by the Royal Adelaide Hospital Research Ethics Committee in April 2014, the Company commenced recruitment and treatment of the first patient with its anti-cancer drug PPL-1. Unfortunately, the first patient passed away due to reasons unrelated to the study drug and this has understandably resulted in a standard process of investigations resulting in delays in the treatment of the second patient.

Now this would say to me that no further approval was needed to commence treatment of the second patient, that a second patient was already recruited, that treatment was due to commence and required investigations on the had be undertaken.

Or have i misread what the announcement infers

DYOR